JP2024535388A5 - - Google Patents
Info
- Publication number
- JP2024535388A5 JP2024535388A5 JP2024518651A JP2024518651A JP2024535388A5 JP 2024535388 A5 JP2024535388 A5 JP 2024535388A5 JP 2024518651 A JP2024518651 A JP 2024518651A JP 2024518651 A JP2024518651 A JP 2024518651A JP 2024535388 A5 JP2024535388 A5 JP 2024535388A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- subject
- conjugate
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248520P | 2021-09-26 | 2021-09-26 | |
| US63/248,520 | 2021-09-26 | ||
| PCT/US2021/058495 WO2022099159A1 (en) | 2020-11-08 | 2021-11-08 | Oligonucleotide compositions and methods thereof |
| USPCT/US2021/058495 | 2021-11-08 | ||
| US202263331756P | 2022-04-15 | 2022-04-15 | |
| US63/331,756 | 2022-04-15 | ||
| US202263397320P | 2022-08-11 | 2022-08-11 | |
| US63/397,320 | 2022-08-11 | ||
| PCT/US2022/044765 WO2023049475A1 (en) | 2021-09-26 | 2022-09-26 | Oligonucleotide compositions and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535388A JP2024535388A (ja) | 2024-09-30 |
| JP2024535388A5 true JP2024535388A5 (enExample) | 2025-10-07 |
Family
ID=85721200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518651A Pending JP2024535388A (ja) | 2021-09-26 | 2022-09-26 | オリゴヌクレオチド組成物及びその方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250333740A1 (enExample) |
| EP (1) | EP4396354A4 (enExample) |
| JP (1) | JP2024535388A (enExample) |
| KR (1) | KR20240063964A (enExample) |
| AU (1) | AU2022352779A1 (enExample) |
| CA (1) | CA3232070A1 (enExample) |
| CL (1) | CL2024000856A1 (enExample) |
| CO (1) | CO2024005352A2 (enExample) |
| IL (1) | IL311625A (enExample) |
| MX (1) | MX2024003612A (enExample) |
| WO (1) | WO2023049475A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2872485T3 (pl) | 2012-07-13 | 2021-05-31 | Wave Life Sciences Ltd. | Asymetryczna grupa pomocnicza |
| BR112016016400A2 (pt) | 2014-01-16 | 2017-10-03 | Wave Life Sciences Ltd | Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos |
| IL320434A (en) | 2015-07-22 | 2025-06-01 | Wave Life Sciences Ltd | Oligonucleotide preparations and methods |
| JP2019520339A (ja) | 2016-06-03 | 2019-07-18 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | オリゴヌクレオチド、その組成物および方法 |
| US11873316B2 (en) | 2016-11-23 | 2024-01-16 | Wave Life Sciences Ltd. | Compositions and methods for phosphoramidite and oligonucleotide synthesis |
| US11718638B2 (en) | 2017-06-21 | 2023-08-08 | Wave Life Sciences Ltd. | Compounds, compositions and methods for synthesis |
| CA3072110A1 (en) | 2017-09-18 | 2019-03-21 | Wave Life Sciences Ltd. | Technologies for oligonucleotide preparation |
| SG11202009877XA (en) | 2018-04-12 | 2020-11-27 | Wave Life Sciences Ltd | Oligonucleotide compositions and methods of use thereof |
| US12391942B2 (en) | 2018-05-11 | 2025-08-19 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| JP2022525541A (ja) | 2019-03-20 | 2022-05-17 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド調製に有用な技術 |
| WO2026077951A1 (en) | 2024-10-07 | 2026-04-16 | Vico Therapeutics B.V. | Improved aon for rna editing |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008086524A2 (en) * | 2007-01-11 | 2008-07-17 | University Of Florida Research Foundation, Inc. | Alpha-1-antitrypsin variants and uses thereof |
| EP3452596A4 (en) * | 2016-05-04 | 2020-03-18 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND RELATED METHODS |
| JP7347830B2 (ja) * | 2018-06-29 | 2023-09-20 | エバーハルト カール ウニヴェルジテート テュービンゲン | Ｒｎａ編集のための人工核酸 |
| KR20210126680A (ko) * | 2019-02-13 | 2021-10-20 | 빔 테라퓨틱스, 인크. | 알파-1 항트립신 결핍증을 치료하기 위한 조성물 및 방법 |
| JP7766589B2 (ja) * | 2019-10-06 | 2025-11-10 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド組成物及びその使用方法 |
| KR20230118716A (ko) * | 2020-11-08 | 2023-08-11 | 웨이브 라이프 사이언시스 리미티드 | 올리고뉴클레오티드 조성물 및 이의 방법 |
-
2022
- 2022-09-26 EP EP22873720.1A patent/EP4396354A4/en active Pending
- 2022-09-26 WO PCT/US2022/044765 patent/WO2023049475A1/en not_active Ceased
- 2022-09-26 MX MX2024003612A patent/MX2024003612A/es unknown
- 2022-09-26 US US18/695,346 patent/US20250333740A1/en active Pending
- 2022-09-26 IL IL311625A patent/IL311625A/en unknown
- 2022-09-26 AU AU2022352779A patent/AU2022352779A1/en active Pending
- 2022-09-26 CA CA3232070A patent/CA3232070A1/en active Pending
- 2022-09-26 JP JP2024518651A patent/JP2024535388A/ja active Pending
- 2022-09-26 KR KR1020247012540A patent/KR20240063964A/ko active Pending
-
2024
- 2024-03-22 CL CL2024000856A patent/CL2024000856A1/es unknown
- 2024-05-07 CO CONC2024/0005352A patent/CO2024005352A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024535388A5 (enExample) | ||
| US7034133B2 (en) | Oligonucleotide analogues | |
| JP5677716B2 (ja) | オリゴヌクレオチド類似体を含むキット及び方法並びにオリゴヌクレオチド類似体の使用 | |
| US8080644B2 (en) | Oligonucleotide analogues | |
| JP2022551124A5 (enExample) | ||
| JP2023548584A5 (enExample) | ||
| US5399676A (en) | Oligonucleotides with inverted polarity | |
| JP2004500330A (ja) | グアニジニウム官能化オリゴマーとその製造法 | |
| JP2002527523A (ja) | 機能付与したピリミジン誘導体 | |
| JPH05504553A (ja) | 新規の結合を有するオリゴヌクレオチドアナログ | |
| JPH09511250A (ja) | 核酸治療に有用な修飾オリゴヌクレオチド及び中間体 | |
| CN1118140A (zh) | 为提高在酸性pH的稳定性而改性的低聚核苷酸 | |
| JPH10509464A (ja) | Ｌ−ヌクレオシド二量体組成物およびその治療目的の使用 | |
| JPH09506770A (ja) | ｃ−ｅｒｂＢの発現が関与する疾患を予防及び治療するためのアンチセンス核酸 | |
| Kiviniemi et al. | Solid-supported 2′-O-glycoconjugation of oligonucleotides by azidation and Click reactions | |
| CN119137272A (zh) | 血管紧张素原调节组合物和其使用方法 | |
| JP3142574B2 (ja) | ２′，５′ホスホロチオエート／ホスホジエステルオリゴアデニレートおよびその抗ウィルス用途 | |
| AU2002325599B2 (en) | Oligonucleotide analogues | |
| Kvasyuk et al. | Nucleotides. Part LVI. Synthesis and biological activity of modified (2′–5′) triadenylates containing 2′‐terminal 2′, 3′‐dideoxy‐3′‐fluoroadenosine derivatives | |
| JP2025526994A5 (enExample) | ||
| Guan et al. | Synthesis and Biological Activity of Modified (2’-5’) Triadenylates Containing 2’-Terminal 2’, 3’-Dideoxy-3’-fluoroadenosine Derivatives | |
| Ademola | Synthetic nucleotides and their biological applications | |
| JPWO1996018640A1 (ja) | アンチセンス核酸同族体 |